Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Traws Pharma, Inc. (TRAW) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Traws Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1130598.
Total stock buying since 2013: $51,884,332.
Total stock sales since 2013: $3,044,149.
Total stock option exercises since 2013: $718,701.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 96,348 | $963 |
| 2024 | 0 | $0 | 0 | $0 | 65,497 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 56,870 | $0 |
| 2022 | 6,000 | $12,420 | 0 | $0 | 21,966 | $0 |
| 2021 | 99,095 | $143,158 | 0 | $0 | 0 | $0 |
| 2020 | 260,678 | $77,239 | 712,231 | $194,254 | 0 | $0 |
| 2019 | 1,218,760 | $253,916 | 717,009 | $1,396,121 | 0 | $0 |
| 2018 | 25,945,408 | $10,665,748 | 99,999 | $45,159 | 0 | $0 |
| 2017 | 160,003 | $336,004 | 0 | $0 | 0 | $0 |
| 2016 | 0 | $0 | 0 | $0 | 170 | $1,079 |
| 2014 | 401,550 | $3,795,926 | 80,000 | $1,205,200 | 139,381 | $614,052 |
| 2013 | 2,451,234 | $36,599,921 | 13,543 | $203,415 | 42,036 | $102,607 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-02 | 0 | $0 | 0 | $0 | 96,348 | $963 |
| 2024-06 | 0 | $0 | 0 | $0 | 5,500 | $0 |
| 2024-03 | 0 | $0 | 0 | $0 | 31,777 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 28,220 | $0 |
| 2023-08 | 0 | $0 | 0 | $0 | 17,317 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 5,500 | $0 |
| 2023-02 | 0 | $0 | 0 | $0 | 34,053 | $0 |
| 2022-08 | 0 | $0 | 0 | $0 | 21,966 | $0 |
| 2022-01 | 6,000 | $12,420 | 0 | $0 | 0 | $0 |
| 2021-11 | 1,000 | $3,160 | 0 | $0 | 0 | $0 |
| 2021-09 | 13,095 | $54,998 | 0 | $0 | 0 | $0 |
| 2021-02 | 85,000 | $85,000 | 0 | $0 | 0 | $0 |
| 2020-12 | 30,000 | $9,600 | 0 | $0 | 0 | $0 |
| 2020-11 | 157,878 | $41,037 | 0 | $0 | 0 | $0 |
| 2020-08 | 0 | $0 | 712,231 | $194,254 | 0 | $0 |
| 2020-05 | 72,800 | $26,602 | 0 | $0 | 0 | $0 |
| 2019-11 | 1,211,500 | $242,300 | 0 | $0 | 0 | $0 |
| 2019-09 | 7,260 | $11,616 | 703,244 | $1,355,507 | 0 | $0 |
| 2019-07 | 0 | $0 | 10,927 | $30,900 | 0 | $0 |
| 2019-06 | 0 | $0 | 2,838 | $9,714 | 0 | $0 |
| 2018-08 | 0 | $0 | 99,999 | $45,159 | 0 | $0 |
| 2018-05 | 10,000 | $3,800 | 0 | $0 | 0 | $0 |
| 2018-04 | 24,585,408 | $9,343,748 | 0 | $0 | 0 | $0 |
| 2018-02 | 1,350,000 | $1,318,200 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-18 | Cautreels Werner (Chief Executive Officer) | Option Ex | 96,348 | .01 | 963 |
| 2024-06-10 | Guerin Mark Patrick (CFO) | Option Ex | 5,500 | .00 | 0 |
| 2024-03-13 | Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) | Option Ex | 23,111 | .00 | 0 |
| 2024-03-13 | Guerin Mark Patrick (CFO AND COO) | Option Ex | 8,666 | .00 | 0 |
| 2024-02-07 | Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) | Option Ex | 21,320 | .00 | 0 |
| 2024-02-07 | Guerin Mark Patrick (CFO AND COO) | Option Ex | 6,900 | .00 | 0 |
| 2023-08-02 | Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) | Option Ex | 12,567 | .00 | 0 |
| 2023-08-02 | Guerin Mark Patrick (CFO AND COO) | Option Ex | 4,750 | .00 | 0 |
| 2023-06-12 | Guerin Mark Patrick (CFO AND COO) | Option Ex | 5,500 | .00 | 0 |
| 2023-02-07 | Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) | Option Ex | 21,320 | .00 | 0 |
| 2023-02-07 | Guerin Mark Patrick (CFO AND COO) | Option Ex | 6,900 | .00 | 0 |
| 2023-02-07 | Gelder Mark S. Md (CHIEF MEDICAL OFFICER) | Option Ex | 5,833 | .00 | 0 |
| 2022-08-02 | Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) | Option Ex | 12,566 | .00 | 0 |
| 2022-08-02 | Guerin Mark Patrick (CFO AND COO) | Option Ex | 4,750 | .00 | 0 |
| 2022-08-02 | Gelder Mark S. Md (CHIEF MEDICAL OFFICER) | Option Ex | 4,650 | .00 | 0 |
| 2022-01-28 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 1,500 | 1.67 | 2,505 |
| 2022-01-21 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 1,500 | 2.02 | 3,030 |
| 2022-01-14 | Oler Abraham N. (SVP CORP DEV & GEN COUNSEL) | Buy | 1,500 | 2.20 | 3,300 |
| 2022-01-07 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 1,500 | 2.39 | 3,585 |
| 2021-11-19 | Oler Abraham N. (SVP CORP DEV & GEN COUNSEL) | Buy | 1,000 | 3.16 | 3,160 |
| 2021-09-28 | Fruchtman Steven M (President, Chief Executive Officer) | Buy | 2,381 | 4.20 | 10,000 |
| 2021-09-28 | Gelder Mark S. Md (Chief Medical Officer) | Buy | 2,381 | 4.20 | 10,000 |
| 2021-09-28 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 2,381 | 4.20 | 10,000 |
| 2021-09-28 | Marino James J | Buy | 5,952 | 4.20 | 24,998 |
| 2021-02-16 | Shoemaker Mary Teresa | Buy | 13,000 | 1.00 | 13,000 |
| 2021-02-16 | Fruchtman Steven M (President, Chief Executive Officer) | Buy | 20,000 | 1.00 | 20,000 |
| 2021-02-16 | Guerin Mark Patrick (Chief Financial Officer) | Buy | 15,000 | 1.00 | 15,000 |
| 2021-02-16 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 12,000 | 1.00 | 12,000 |
| 2021-02-16 | Marino James J | Buy | 25,000 | 1.00 | 25,000 |
| 2020-12-11 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 30,000 | .32 | 9,600 |
| 2020-11-27 | Guerin Mark Patrick (Chief Financial Officer) | Buy | 4,614 | .26 | 1,199 |
| 2020-11-25 | Shoemaker Mary Teresa | Buy | 37,735 | .27 | 9,999 |
| 2020-11-25 | Fruchtman Steven M (President, Chief Executive Officer) | Buy | 40,000 | .26 | 10,360 |
| 2020-11-25 | Guerin Mark Patrick (Chief Financial Officer) | Buy | 16,755 | .26 | 4,356 |
| 2020-11-25 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 20,000 | .26 | 5,120 |
| 2020-11-24 | Marino James J | Buy | 38,774 | .26 | 10,003 |
| 2020-08-27 | Reddy E Premkumar | Sale | 527,863 | .27 | 144,106 |
| 2020-08-27 | Hoffman Michael B | Sale | 184,368 | .27 | 50,148 |
| 2020-05-19 | Fruchtman Steven M (President, Chief Executive Officer) | Buy | 26,800 | .37 | 9,862 |
| 2020-05-19 | Guerin Mark Patrick (Chief Financial Officer) | Buy | 21,000 | .36 | 7,560 |
| 2020-05-19 | Oler Abraham N. (SVP Corp Dev & Gen Counsel) | Buy | 15,000 | .37 | 5,550 |
| 2020-05-19 | Groopman Jerome | Buy | 10,000 | .36 | 3,630 |
| 2019-11-25 | Fruchtman Steven M (President, Chief Executive Officer) | Buy | 149,000 | .20 | 29,800 |
| 2019-11-25 | Guerin Mark Patrick (Chief Financial Officer) | Buy | 87,500 | .20 | 17,500 |
| 2019-11-25 | Reddy E Premkumar | Buy | 500,000 | .20 | 100,000 |
| 2019-11-25 | Oler Abraham N. (VP Corp Dev & Gen Counsel) | Buy | 75,000 | .20 | 15,000 |
| 2019-11-25 | Mehta Viren | Buy | 250,000 | .20 | 50,000 |
| 2019-11-25 | Marino James J | Buy | 150,000 | .20 | 30,000 |
| 2019-09-25 | Marino James J | Buy | 7,260 | 1.60 | 11,616 |
| 2019-09-24 | Tyndall Capital Partners L P | Sale | 16,700 | 1.19 | 19,873 |
| 2019-09-23 | Boyd Steven | Sale | 10,249 | .64 | 6,508 |
| 2019-09-23 | Tyndall Capital Partners L P | Sale | 37,242 | 1.23 | 45,956 |
| 2019-09-20 | Tyndall Capital Partners L P | Sale | 75,119 | 1.62 | 121,467 |
| 2019-09-18 | Zweiman Ari | Sale | 506,877 | 2.05 | 1,037,070 |
| 2019-09-18 | Tyndall Capital Partners L P | Sale | 49,995 | 2.10 | 105,039 |
| 2019-09-11 | Tyndall Capital Partners L P | Sale | 1,247 | 2.75 | 3,432 |
| 2019-09-09 | Tyndall Capital Partners L P | Sale | 400 | 2.77 | 1,106 |
| 2019-09-06 | Tyndall Capital Partners L P | Sale | 5,015 | 2.78 | 13,956 |
| 2019-09-05 | Tyndall Capital Partners L P | Sale | 400 | 2.75 | 1,100 |
| 2019-07-10 | Tyndall Capital Partners L P | Sale | 2,742 | 2.81 | 7,696 |
| 2019-07-09 | Tyndall Capital Partners L P | Sale | 8,185 | 2.83 | 23,204 |
| 2019-06-27 | Tyndall Capital Partners L P | Sale | 1,458 | 3.45 | 5,025 |
| 2019-06-25 | Tyndall Capital Partners L P | Sale | 1,380 | 3.40 | 4,689 |
| 2018-08-29 | Hoffman Michael B (Director) | Sale | 29,999 | .45 | 13,529 |
| 2018-08-28 | Hoffman Michael B (Director) | Sale | 50,000 | .45 | 22,550 |
| 2018-08-27 | Hoffman Michael B (Director) | Sale | 20,000 | .45 | 9,080 |
| 2018-05-29 | Bienen Henry S | Buy | 10,000 | .38 | 3,800 |
| 2018-04-27 | Reddy E Premkumar | Buy | 282,350 | .00 | 0 |
| 2018-04-27 | 683 Capital Management, Llc | Buy | 11,838,235 | .42 | 5,031,249 |
| 2018-04-27 | Hoffman Michael B | Buy | 2,211,765 | .00 | 0 |
| 2018-04-27 | Tyndall Capital Partners L P | Buy | 10,147,058 | .42 | 4,312,499 |
| 2018-04-27 | Stover Jack E | Buy | 47,100 | .00 | 0 |
| 2018-04-27 | Marino James J | Buy | 58,900 | .00 | 0 |
| 2018-02-08 | 683 Capital Partners, Lp | Buy | 200,000 | 1.04 | 207,200 |
| 2018-02-08 | Tyndall Capital Partners L P | Buy | 1,100,000 | 1.01 | 1,111,000 |
| 2018-02-08 | Marino James J | Buy | 50,000 | .00 | 0 |
| 2017-04-26 | Guerin Mark Patrick (Chief Financial Officer) | Buy | 1,429 | 2.10 | 3,000 |
| 2017-04-26 | Kumar Ramesh (President and CEO) | Buy | 23,810 | 2.10 | 50,001 |
| 2017-04-26 | Reddy E Premkumar | Buy | 119,048 | 2.10 | 250,000 |
| 2017-04-26 | Bienen Henry S | Buy | 3,810 | 2.10 | 8,001 |
| 2017-04-26 | Marino James J | Buy | 11,906 | 2.10 | 25,002 |
| 2016-06-30 | Maniar Manoj (SVP - Product Development) | Option Ex | 50 | 6.50 | 325 |
| 2016-06-29 | Groopman Jerome | Option Ex | 10 | 5.20 | 52 |
| 2016-06-27 | Marino James J | Option Ex | 10 | 5.20 | 52 |
| 2016-06-24 | Fruchtman Steven M (Chief Medical Officer) | Option Ex | 100 | 6.50 | 650 |
| 2014-07-07 | Hoffman Michael B | Option Ex | 18,754 | 2.67 | 50,073 |
| 2014-05-02 | Reddy E Premkumar | Option Ex | 27,084 | 1.33 | 36,021 |
| 2014-02-21 | Michael & Jane Hoffman 2013 Descendants | Buy | 71,740 | 8.91 | 639,203 |
| 2014-02-21 | Hoffman Michael B | Buy | 71,740 | 8.91 | 639,203 |
| 2014-02-20 | Michael & Jane Hoffman 2013 Descendants | Buy | 71,740 | 8.03 | 576,072 |
| 2014-02-20 | Hoffman Michael B | Buy | 71,740 | 8.03 | 576,072 |
| 2014-02-10 | Kumar Ramesh (President and CEO) | Sale | 20,000 | 15.11 | 302,200 |
| 2014-02-10 | Kumar Ramesh (President and CEO) | Option Ex | 20,000 | 6.00 | 120,000 |
| 2014-02-07 | Kumar Ramesh (President and CEO) | Option Ex | 13,543 | 6.00 | 81,258 |
| 2014-02-03 | Kumar Ramesh (President and CEO) | Sale | 20,000 | 15.07 | 301,400 |
| 2014-02-03 | Kumar Ramesh (President and CEO) | Option Ex | 20,000 | 6.00 | 120,000 |
| 2014-01-31 | Kumar Ramesh (President and CEO) | Sale | 20,000 | 15.03 | 300,600 |
| 2014-01-31 | Kumar Ramesh (President and CEO) | Option Ex | 20,000 | 6.00 | 120,000 |
| 2014-01-30 | Kumar Ramesh (President and CEO) | Sale | 20,000 | 15.05 | 301,000 |
| 2014-01-30 | Kumar Ramesh (President and CEO) | Option Ex | 20,000 | 4.33 | 86,700 |
| 2014-01-27 | Michael & Jane Hoffman 2013 Descendants | Buy | 25,589 | 11.86 | 303,485 |
| 2014-01-27 | Hoffman Michael B | Buy | 25,589 | 11.86 | 303,485 |
| 2014-01-24 | Michael & Jane Hoffman 2013 Descendants | Buy | 31,706 | 11.96 | 379,203 |
| 2014-01-24 | Hoffman Michael B | Buy | 31,706 | 11.96 | 379,203 |
| 2013-12-19 | Reddy E Premkumar | Option Ex | 32,036 | 1.33 | 42,607 |
| 2013-11-22 | Michael & Jane Hoffman 2013 Descendants | Buy | 5,000 | 14.38 | 71,900 |
| 2013-11-22 | Hoffman Michael B | Buy | 5,000 | 14.38 | 71,900 |
| 2013-11-18 | Michael & Jane Hoffman 2013 Descendants | Buy | 5,000 | 11.87 | 59,349 |
| 2013-11-18 | Reddy E Premkumar | Buy | 5,000 | 12.10 | 60,500 |
| 2013-11-18 | Hoffman Michael B | Buy | 5,000 | 11.87 | 59,349 |
| 2013-11-15 | Michael & Jane Hoffman 2013 Descendants | Buy | 19,700 | 12.03 | 236,991 |
| 2013-11-15 | Kumar Ramesh (President and CEO) | Buy | 1,100 | 12.02 | 13,222 |
| 2013-11-15 | Bienen Henry S | Buy | 1,400 | 12.13 | 16,989 |
| 2013-11-15 | Hoffman Michael B | Buy | 19,700 | 12.03 | 236,991 |
| 2013-10-10 | Altland James (SVP, Finance & Corp. Develop.) | Option Ex | 5,000 | 6.00 | 30,000 |
| 2013-07-30 | Michael & Jane Hoffman 2013 Descendants | Buy | 1,000,000 | 15.00 | 15,000,000 |
| 2013-07-30 | Altland James (SVP, Finance & Corp. Develop.) | Option Ex | 5,000 | 6.00 | 30,000 |
| 2013-07-30 | Kumar Ramesh (President and CEO) | Buy | 6,667 | 15.00 | 100,005 |
| 2013-07-30 | Reddy E Premkumar | Buy | 20,000 | 15.00 | 300,000 |
| 2013-07-30 | Bienen Henry S | Buy | 6,667 | 15.00 | 100,005 |
| 2013-07-30 | Hoffman Michael B | Buy | 1,000,000 | 15.00 | 15,000,000 |
| 2013-07-30 | Mehta Viren | Buy | 16,667 | 15.00 | 250,005 |
| 2013-07-30 | Mckearn Thomas J (President, R&D) | Buy | 3,333 | 15.00 | 49,995 |
| 2013-07-30 | Baxter International Inc | Buy | 330,000 | 15.00 | 4,950,000 |
| 2013-07-25 | Reddy E Premkumar | Buy | 1,000 | 22.72 | 22,720 |
| 2013-02-07 | Kumar Ramesh (President and CEO) | Sale | 13,543 | 15.02 | 203,415 |
Insider trading activities including stock purchases, stock sales, and option exercises of TRAW listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Traws Pharma, Inc. (symbol TRAW, CIK number 1130598) see the Securities and Exchange Commission (SEC) website.